Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lighton | Paris | 73.9% | €9.18Cr | 0.01 | €14.72 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||||
Orinoquia Real Estate SOCIMI | Paris | Real Estate | Residential & Commercial REITs | 14.3% | €2.28Cr | 26.4x | €1.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | 11.2% | €16.05Cr | 3.4x | 0.02 | €7.40 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gaztransport et Technigaz SA | Paris | Energy | Oil & Gas Related Equipment and Services | 3.3% | €492Cr | 17.1x | 0.19 | €133.10 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.4% Upside | Upgrade to Pro+ | |
Courtois | Paris | Real Estate | Real Estate Operations | 0.8% | €86.80L | -30.3x | 1.12 | €120 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | 0% | €19.21Cr | 8.5x | 0.05 | €3.77 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hydro Exploitations | Paris | Utilities | Electrical Utilities & IPPs | 0% | €1.35Cr | 9.3x | 0.01 | €110 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IDI | Paris | Financial | Investment Banking & Investment Services | -0.9% | €46.78Cr | -390.5x | €65.60 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.2% Upside | Upgrade to Pro+ | ||
DBV Technologies | Paris | Healthcare | Pharmaceuticals | -19.7% | €7.43Cr | -0.8x | -1.09 | €0.76 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | -30.5% | €51.87Cr | -2.6x | -1.61 | €8.06 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | -40.2% | €13.18Cr | -3.6x | -0.08 | €2.79 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |